9-72 tissue plasminogen
activator,69-71 reteplase,69-71 and tenecteplase73 for venous
thrombolysis.
A consensus panel of the Society of Interventional
Radiology has reviewed recommended thrombolytic dosages and techniques for their catheter-directed administration.68 Because patient characteristics and bleeding risks
vary, individual judgment is required in the selection of
appropriate thrombolytic